25 XP   0   0   10

Evolus Inc
Buy, Hold or Sell?

Let's analyse Evolus together

PenkeI guess you are interested in Evolus Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Evolus Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Evolus Inc

I send you an email if I find something interesting about Evolus Inc.

Quick analysis of Evolus (30 sec.)










What can you expect buying and holding a share of Evolus? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.34
Expected worth in 1 year
$-0.97
How sure are you?
23.3%

+ What do you gain per year?

Total Gains per Share
$-0.64
Return On Investment
-5.5%

For what price can you sell your share?

Current Price per Share
$11.50
Expected price per share
$11.27 - $13.55
How sure are you?
50%

1. Valuation of Evolus (5 min.)




Live pricePrice per Share (EOD)

$11.50

Intrinsic Value Per Share

$-8.64 - $-9.77

Total Value Per Share

$-8.98 - $-10.11

2. Growth of Evolus (5 min.)




Is Evolus growing?

Current yearPrevious yearGrowGrow %
How rich?-$20.6m$33.1m-$43.1m-431.0%

How much money is Evolus making?

Current yearPrevious yearGrowGrow %
Making money-$15.4m-$18.6m$3.1m20.6%
Net Profit Margin-31.5%-51.2%--

How much money comes from the company's main activities?

3. Financial Health of Evolus (5 min.)




What can you expect buying and holding a share of Evolus? (5 min.)

Welcome investor! Evolus's management wants to use your money to grow the business. In return you get a share of Evolus.

What can you expect buying and holding a share of Evolus?

First you should know what it really means to hold a share of Evolus. And how you can make/lose money.

Speculation

The Price per Share of Evolus is $11.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Evolus.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Evolus, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.34. Based on the TTM, the Book Value Change Per Share is $-0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Evolus.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.19-1.7%-0.25-2.2%-0.30-2.6%-0.35-3.1%-0.29-2.5%
Usd Book Value Change Per Share-0.02-0.2%-0.16-1.4%-0.26-2.2%-0.09-0.7%-0.01-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-0.2%-0.16-1.4%-0.26-2.2%-0.09-0.7%-0.01-0.1%
Usd Price Per Share10.53-8.85-9.60-9.76-8.76-
Price to Earnings Ratio-13.68--9.24--8.08--6.71--7.40-
Price-to-Total Gains Ratio-490.21--153.18--16.93--50.63--49.16-
Price to Book Ratio-31.30--12.42-4,248.20-855.80-573.10-
Price-to-Total Gains Ratio-490.21--153.18--16.93--50.63--49.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.5
Number of shares86
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.16-0.09
Usd Total Gains Per Share-0.16-0.09
Gains per Quarter (86 shares)-13.70-7.35
Gains per Year (86 shares)-54.80-29.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-55-650-29-39
20-110-1200-59-68
30-164-1750-88-97
40-219-2300-118-126
50-274-2850-147-155
60-329-3400-176-184
70-384-3950-206-213
80-438-4500-235-242
90-493-5050-264-271
100-548-5600-294-300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%3.027.00.010.0%3.027.00.010.0%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%7.021.02.023.3%7.021.02.023.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.030.00.0%0.00.030.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%7.021.02.023.3%7.021.02.023.3%

Fundamentals of Evolus

About Evolus Inc

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Fundamental data was last updated by Penke on 2024-04-11 06:59:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Evolus Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Evolus earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Evolus to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -19.4% means that $-0.19 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Evolus Inc:

  • The MRQ is -19.4%. The company is making a huge loss. -2
  • The TTM is -31.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-19.4%TTM-31.5%+12.1%
TTM-31.5%YOY-51.2%+19.7%
TTM-31.5%5Y-171.5%+140.0%
5Y-171.5%10Y-114.3%-57.2%
1.1.2. Return on Assets

Shows how efficient Evolus is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Evolus to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.3% Return on Assets means that Evolus generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Evolus Inc:

  • The MRQ is -6.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-9.1%+2.8%
TTM-9.1%YOY-2,636.9%+2,627.8%
TTM-9.1%5Y-536.2%+527.2%
5Y-536.2%10Y-360.3%-176.0%
1.1.3. Return on Equity

Shows how efficient Evolus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Evolus to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Evolus generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Evolus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-53.2%+53.2%
TTM-53.2%YOY-17,384.5%+17,331.3%
TTM-53.2%5Y-3,507.7%+3,454.4%
5Y-3,507.7%10Y-2,350.0%-1,157.7%

1.2. Operating Efficiency of Evolus Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Evolus is operating .

  • Measures how much profit Evolus makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Evolus to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -8.3% means the company generated $-0.08  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Evolus Inc:

  • The MRQ is -8.3%. The company is operating very inefficient. -2
  • The TTM is -24.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8.3%TTM-24.1%+15.8%
TTM-24.1%YOY-39.8%+15.7%
TTM-24.1%5Y-144.7%+120.6%
5Y-144.7%10Y-96.5%-48.2%
1.2.2. Operating Ratio

Measures how efficient Evolus is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are $1.08 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Evolus Inc:

  • The MRQ is 1.083. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.200. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.083TTM1.200-0.117
TTM1.200YOY1.398-0.198
TTM1.2005Y2.390-1.189
5Y2.39010Y1.593+0.797

1.3. Liquidity of Evolus Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Evolus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.33 means the company has $2.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Evolus Inc:

  • The MRQ is 2.328. The company is able to pay all its short-term debts. +1
  • The TTM is 2.156. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.328TTM2.156+0.172
TTM2.156YOY2.635-0.479
TTM2.1565Y3.945-1.789
5Y3.94510Y4.752-0.807
1.3.2. Quick Ratio

Measures if Evolus is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Evolus to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.93 means the company can pay off $1.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Evolus Inc:

  • The MRQ is 1.933. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.604. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.933TTM1.604+0.329
TTM1.604YOY2.103-0.498
TTM1.6045Y4.647-3.042
5Y4.64710Y5.860-1.213

1.4. Solvency of Evolus Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Evolus assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Evolus to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.11 means that Evolus assets are financed with 110.9% credit (debt) and the remaining percentage (100% - 110.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Evolus Inc:

  • The MRQ is 1.109. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.056. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.109TTM1.056+0.054
TTM1.056YOY0.804+0.251
TTM1.0565Y0.839+0.217
5Y0.83910Y0.862-0.023
1.4.2. Debt to Equity Ratio

Measures if Evolus is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Evolus to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Evolus Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.515-5.515
TTM5.515YOY5.000+0.515
TTM5.5155Y3.945+1.569
5Y3.94510Y3.211+0.734

2. Market Valuation of Evolus Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Evolus generates.

  • Above 15 is considered overpriced but always compare Evolus to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -13.68 means the investor is paying $-13.68 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Evolus Inc:

  • The EOD is -14.944. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.684. Based on the earnings, the company is expensive. -2
  • The TTM is -9.236. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.944MRQ-13.684-1.261
MRQ-13.684TTM-9.236-4.448
TTM-9.236YOY-8.083-1.153
TTM-9.2365Y-6.714-2.522
5Y-6.71410Y-7.400+0.687
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Evolus Inc:

  • The EOD is 391.163. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 358.169. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 84.942. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD391.163MRQ358.169+32.994
MRQ358.169TTM84.942+273.227
TTM84.942YOY-5.275+90.217
TTM84.9425Y10.866+74.075
5Y10.86610Y0.455+10.411
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Evolus is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -31.30 means the investor is paying $-31.30 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Evolus Inc:

  • The EOD is -34.183. Based on the equity, the company is expensive. -2
  • The MRQ is -31.300. Based on the equity, the company is expensive. -2
  • The TTM is -12.415. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-34.183MRQ-31.300-2.883
MRQ-31.300TTM-12.415-18.885
TTM-12.415YOY4,248.202-4,260.617
TTM-12.4155Y855.804-868.219
5Y855.80410Y573.096+282.708
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Evolus Inc.

3.1. Institutions holding Evolus Inc

Institutions are holding 76.863% of the shares of Evolus Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Nantahala Capital Management, LLC9.46651.8336582169854004781282.1039
2023-12-31Stonepine Capital Management Llc8.671924.286253330041540002.9735
2023-12-31Perceptive Advisors LLC6.44480.931639634242477623166.7534
2023-12-31BlackRock Inc5.43010.0009333937736583912.3032
2023-09-30TANG CAPITAL MANAGEMENT LLC5.03663.9948309739900
2023-12-31Vanguard Group Inc4.78640.000729435122448659.0736
2023-12-31Morgan Stanley - Brokerage Accounts4.19970.002425827112056136390.4735
2023-12-31Great Point Partners LLC3.25223.58942000000-186934-8.5478
2023-12-31Deutsche Bank AG2.30010.0076141452613936086662.243
2023-12-31Caligan Partners LP2.14294.67991317856-365980-21.7349
2023-12-31Schroder Investment Management Group1.88910.01591161738-590857-33.7133
2023-12-31State Street Corporation1.6690.00051026374418314.2488
2023-12-31Millennium Management LLC1.6320.00461003617-146490-12.7371
2023-12-31Geode Capital Management, LLC1.51920.001934276647837.4507
2023-12-31Nuveen Asset Management, LLC1.50070.0031922904-351265-27.5682
2023-12-31Rice Hall James & Associates, LLC1.47350.5526906195-198964-18.0032
2023-12-31BOOTHBAY FUND MANAGEMENT, LLC1.36090.2249836925-325980-28.0315
2023-12-31UBS Group AG1.08340.0021666285-108096-13.959
2023-12-31AWH Capital, L.P.1.02326.655629240-198260-23.9589
2023-12-31Marshall Wace Asset Management Ltd0.90010.0099553526-121830-18.0394
Total 65.782346.796740454587+9604507+23.7%

3.2. Funds holding Evolus Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.48020.00151525261-115300-7.0281
2024-03-28iShares Russell 2000 ETF1.66610.021910246314950.0483
2023-12-31Schroder US Smaller Companies Acc1.24960.862276847100
2024-02-29Xtrackers S&P 500 Swap ETF 1C1.18940.119973142600
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.05640.0094649635-809-0.1244
2024-01-31TIAA-CREF Quant Small-Cap Equity Instl0.73830.192445403000
2024-01-31Fidelity Small Cap Index0.68140.021541903035190.8469
2023-12-31Oberweis Micro-Cap Growth0.60390.86493714003714000
2023-12-31Oberweis Micro-Cap0.60390.86563714003714000
2024-03-28iShares Russell 2000 Growth ETF0.59820.0442367854-428-0.1162
2023-12-31Schroder U.S. Small Cap Core0.43120.926526517000
2024-02-29Fidelity Extended Market Index0.41480.009925509786253.4994
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.40770.008925069633001.3339
2024-02-29Hartford Schroders US Small Cap Opps I0.36751.2734226006-20623-8.362
2024-02-29Vanguard Health Care ETF0.26960.0118165828117117.5988
2024-02-29Vanguard Russell 2000 ETF0.24460.0234150420117488.4718
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.23880.021114683400
2023-12-31NT R2000 Growth Index Fund - NL0.20160.035312395700
2023-12-31NT R2000 Index Fund - NL0.19330.01731188882040.1719
2024-02-29Russell Inv Tax-Managed US Mid&Sm Cap S0.18170.103211176900
Total 13.81825.43438497803+645242+7.6%

3.3. Insider Transactions

Insiders are holding 13.064% of the shares of Evolus Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-27David MoatazediSELL623613.86
2024-03-19Rui AvelarSELL2760313.92
2024-03-19Sandra BeaverSELL567213.92
2024-02-22David MoatazediSELL770613.08
2024-02-22Sandra BeaverSELL182113.08
2024-01-30Karah Herdman ParschauerSELL1193113.14
2023-12-08David MoatazediSELL313009.73
2023-12-06David MoatazediSELL5134810.09
2023-10-16Medytox Inc.SELL16906637.5
2023-09-06Sandra BeaverSELL31789.7
2023-08-16Rui AvelarSELL221110.27
2023-08-15Vikram MalikBUY1749677.41

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Evolus Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.021-0.159+642%-0.258+1099%-0.085+298%-0.011-48%
Book Value Per Share---0.336-0.163-52%0.539-162%0.555-161%0.462-173%
Current Ratio--2.3282.156+8%2.635-12%3.945-41%4.752-51%
Debt To Asset Ratio--1.1091.056+5%0.804+38%0.839+32%0.862+29%
Debt To Equity Ratio---5.515-100%5.000-100%3.945-100%3.211-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.192-0.251+30%-0.302+57%-0.354+84%-0.288+50%
Free Cash Flow Per Share--0.007-0.283+3946%-0.667+9170%-0.347+4822%-0.273+3812%
Free Cash Flow To Equity Per Share--0.390-0.010+102%-0.694+278%-0.100+126%-0.021+105%
Gross Profit Margin--1.0001.0000%1.0000%1.0020%1.0010%
Intrinsic Value_10Y_max---9.772--------
Intrinsic Value_10Y_min---8.640--------
Intrinsic Value_1Y_max---1.386--------
Intrinsic Value_1Y_min---1.361--------
Intrinsic Value_3Y_max---3.853--------
Intrinsic Value_3Y_min---3.685--------
Intrinsic Value_5Y_max---5.948--------
Intrinsic Value_5Y_min---5.547--------
Market Cap707222400.000+8%647569728.000544253760.000+19%590069472.000+10%600370320.000+8%538698476.800+20%
Net Profit Margin---0.194-0.315+62%-0.512+164%-1.715+784%-1.143+489%
Operating Margin---0.083-0.241+189%-0.398+378%-1.447+1637%-0.965+1058%
Operating Ratio--1.0831.200-10%1.398-23%2.390-55%1.593-32%
Pb Ratio-34.183-9%-31.300-12.415-60%4248.202-101%855.804-104%573.096-105%
Pe Ratio-14.944-9%-13.684-9.236-33%-8.083-41%-6.714-51%-7.400-46%
Price Per Share11.500+8%10.5308.850+19%9.595+10%9.763+8%8.760+20%
Price To Free Cash Flow Ratio391.163+8%358.16984.942+322%-5.275+101%10.866+3196%0.455+78610%
Price To Total Gains Ratio-535.369-9%-490.212-153.176-69%-16.932-97%-50.626-90%-49.158-90%
Quick Ratio--1.9331.604+21%2.103-8%4.647-58%5.860-67%
Return On Assets---0.063-0.091+45%-26.369+42023%-5.362+8466%-3.603+5655%
Return On Equity----0.5320%-173.8450%-35.0770%-23.5000%
Total Gains Per Share---0.021-0.159+642%-0.258+1099%-0.085+298%-0.011-48%
Usd Book Value---20689000.000-10017750.000-52%33159305.000-162%34132861.000-161%28383474.000-173%
Usd Book Value Change Per Share---0.021-0.159+642%-0.258+1099%-0.085+298%-0.011-48%
Usd Book Value Per Share---0.336-0.163-52%0.539-162%0.555-161%0.462-173%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.192-0.251+30%-0.302+57%-0.354+84%-0.288+50%
Usd Free Cash Flow--452000.000-17383000.000+3946%-40997250.000+9170%-21342950.000+4822%-16779066.667+3812%
Usd Free Cash Flow Per Share--0.007-0.283+3946%-0.667+9170%-0.347+4822%-0.273+3812%
Usd Free Cash Flow To Equity Per Share--0.390-0.010+102%-0.694+278%-0.100+126%-0.021+105%
Usd Market Cap707222400.000+8%647569728.000544253760.000+19%590069472.000+10%600370320.000+8%538698476.800+20%
Usd Price Per Share11.500+8%10.5308.850+19%9.595+10%9.763+8%8.760+20%
Usd Profit---11831000.000-15421250.000+30%-18603000.000+57%-21797700.000+84%-17405200.000+47%
Usd Revenue--60999000.00050347250.000+21%37154000.000+64%27057150.000+125%18038100.000+238%
Usd Total Gains Per Share---0.021-0.159+642%-0.258+1099%-0.085+298%-0.011-48%
 EOD+5 -3MRQTTM+25 -7YOY+23 -95Y+23 -1010Y+19 -14

4.2. Fundamental Score

Let's check the fundamental score of Evolus Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.944
Price to Book Ratio (EOD)Between0-1-34.183
Net Profit Margin (MRQ)Greater than0-0.194
Operating Margin (MRQ)Greater than0-0.083
Quick Ratio (MRQ)Greater than11.933
Current Ratio (MRQ)Greater than12.328
Debt to Asset Ratio (MRQ)Less than11.109
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.063
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Evolus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.683
Ma 20Greater thanMa 5012.675
Ma 50Greater thanMa 10013.468
Ma 100Greater thanMa 20012.262
OpenGreater thanClose11.680
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets188,998
Total Liabilities209,687
Total Stockholder Equity-20,689
 As reported
Total Liabilities 209,687
Total Stockholder Equity+ -20,689
Total Assets = 188,998

Assets

Total Assets188,998
Total Current Assets112,421
Long-term Assets76,577
Total Current Assets
Cash And Cash Equivalents 62,838
Net Receivables 30,529
Inventory 10,998
Other Current Assets 8,056
Total Current Assets  (as reported)112,421
Total Current Assets  (calculated)112,421
+/-0
Long-term Assets
Property Plant Equipment 7,850
Goodwill 21,208
Intangible Assets 47,110
Long-term Assets Other 409
Long-term Assets  (as reported)76,577
Long-term Assets  (calculated)76,577
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities48,291
Long-term Liabilities161,396
Total Stockholder Equity-20,689
Total Current Liabilities
Short-term Debt 1,377
Accounts payable 4,271
Other Current Liabilities 31,610
Total Current Liabilities  (as reported)48,291
Total Current Liabilities  (calculated)37,258
+/- 11,033
Long-term Liabilities
Long term Debt 120,359
Capital Lease Obligations 6,187
Long-term Liabilities  (as reported)161,396
Long-term Liabilities  (calculated)126,546
+/- 34,850
Total Stockholder Equity
Common Stock1
Retained Earnings -558,979
Accumulated Other Comprehensive Income -427
Other Stockholders Equity 538,716
Total Stockholder Equity (as reported)-20,689
Total Stockholder Equity (calculated)-20,689
+/-0
Other
Capital Stock1
Cash and Short Term Investments 62,838
Common Stock Shares Outstanding 57,246
Current Deferred Revenue11,033
Liabilities and Stockholders Equity 188,998
Net Debt 63,708
Net Invested Capital 99,670
Net Working Capital 64,130
Property Plant and Equipment Gross 7,850
Short Long Term Debt Total 126,546



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
> Total Assets 
81,301
77,495
0
0
78,957
152,233
127,395
121,934
183,377
171,844
220,929
202,781
182,666
240,442
214,151
194,544
215,779
209,068
157,198
239,863
215,220
257,483
220,662
210,919
193
177,983
160,235
168,983
167,971
188,998
188,998167,971168,983160,235177,983193210,919220,662257,483215,220239,863157,198209,068215,779194,544214,151240,442182,666202,781220,929171,844183,377121,934127,395152,23378,9570077,49581,301
   > Total Current Assets 
4,017
211
0
0
290
72,824
50,111
44,623
106,092
94,339
139,084
115,826
95,184
152,197
126,142
107,998
132,400
127,612
77,717
161,890
138,344
178,799
142,928
133,947
116
100,802
84,085
96,460
91,999
112,421
112,42191,99996,46084,085100,802116133,947142,928178,799138,344161,89077,717127,612132,400107,998126,142152,19795,184115,826139,08494,339106,09244,62350,11172,824290002114,017
       Cash And Cash Equivalents 
4,000
187
0
0
0
0
49,570
43,585
105,168
93,162
54,367
30,289
39,116
109,892
34,652
29,772
85,127
102,562
22,171
131,737
107,796
146,256
106,671
84,484
66
53,922
31,463
41,705
38,685
62,838
62,83838,68541,70531,46353,9226684,484106,671146,256107,796131,73722,171102,56285,12729,77234,652109,89239,11630,28954,36793,162105,16843,58549,57000001874,000
       Short-term Investments 
4,000
187
0
0
0
0
0
0
0
0
79,313
69,640
34,913
19,911
64,987
54,982
24,996
5,000
5,000
0
0
146,256
0
0
0
0
0
0
0
0
00000000146,256005,0005,00024,99654,98264,98719,91134,91369,64079,313000000001874,000
       Net Receivables 
0
0
0
0
0
72,639
72,639
0
0
0
0
1,410
7,206
10,661
10,406
8,649
11,399
9,680
40,579
11,864
13,289
14,657
16,800
21,026
21
22,448
23,455
28,996
30,464
30,529
30,52930,46428,99623,45522,4482121,02616,80014,65713,28911,86440,5799,68011,3998,64910,40610,6617,2061,410000072,63972,63900000
       Inventory 
0
0
0
0
0
0
0
0
0
0
2,578
11,522
10,043
6,407
12,542
10,343
4,871
3,354
2,775
3,337
3,816
1,762
3,615
12,289
22
18,852
23,418
19,859
17,626
10,998
10,99817,62619,85923,41818,8522212,2893,6151,7623,8163,3372,7753,3544,87110,34312,5426,40710,04311,5222,5780000000000
   > Long-term Assets 
0
77,284
0
0
78,667
79,409
77,284
77,311
77,285
77,505
81,845
86,955
87,482
88,245
88,009
86,546
83,379
81,456
79,481
77,973
76,876
78,684
77,734
76,972
77
77,181
76,150
72,523
75,972
76,577
76,57775,97272,52376,15077,1817776,97277,73478,68476,87677,97379,48181,45683,37986,54688,00988,24587,48286,95581,84577,50577,28577,31177,28479,40978,6670077,2840
       Property Plant Equipment 
0
0
0
0
0
0
0
5
1
0
810
5,330
5,222
4,970
5,332
5,160
4,940
4,711
4,465
4,215
3,960
4,093
3,840
3,801
4
4,563
4,333
3,876
8,037
7,850
7,8508,0373,8764,3334,56343,8013,8404,0933,9604,2154,4654,7114,9405,1605,3324,9705,2225,3308100150000000
       Goodwill 
21,208
21,208
0
0
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21,208
21
21,208
21,208
21,208
21,208
21,208
21,20821,20821,20821,20821,2082121,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,20821,2080021,20821,208
       Intangible Assets 
77,284
56,076
0
0
56,076
56,076
56,076
56,076
56,076
56,076
58,782
59,211
59,857
59,638
59,174
58,023
56,791
55,297
53,568
52,310
51,468
50,625
50,032
49,415
49
48,597
47,927
47,216
46,505
47,110
47,11046,50547,21647,92748,5974949,41550,03250,62551,46852,31053,56855,29756,79158,02359,17459,63859,85759,21158,78256,07656,07656,07656,07656,07656,0760056,07677,284
       Long-term Assets Other 
0
0
0
0
1,383
2,125
2,125
22
0
221
1,045
1,206
1,195
2,429
2,295
2,155
440
240
240
240
240
2,758
2,654
2,548
2
2,813
2,682
223
222
409
4092222232,6822,81322,5482,6542,7582402402402404402,1552,2952,4291,1951,2061,0452210222,1252,1251,3830000
> Total Liabilities 
69,299
84,601
0
0
94,518
227,776
75,413
83,999
88,411
87,460
145,572
161,600
165,623
160,985
151,545
150,941
180,684
282,026
133,909
133,725
117,816
175,607
153,414
164,058
163
159,484
153,286
175,946
187,339
209,687
209,687187,339175,946153,286159,484163164,058153,414175,607117,816133,725133,909282,026180,684150,941151,545160,985165,623161,600145,57287,46088,41183,99975,413227,77694,5180084,60169,299
   > Total Current Liabilities 
48,101
63,312
0
0
30,064
212,748
3,629
3,684
5,460
5,276
9,400
23,105
25,974
24,439
22,613
19,462
12,709
180,248
87,648
87,286
71,303
57,663
40,700
51,531
51
46,509
40,678
41,349
48,540
48,291
48,29148,54041,34940,67846,5095151,53140,70057,66371,30387,28687,648180,24812,70919,46222,61324,43925,97423,1059,4005,2765,4603,6843,629212,74830,0640063,31248,101
       Short-term Debt 
46,167
59,760
59,760
0
28,900
211,326
0
0
0
0
802
1,031
1,148
1,200
1,195
1,182
1,197
94,664
20,580
20,887
21,202
1,265
1,279
1,293
1,307
1,320
1,334
1,349
1,363
1,377
1,3771,3631,3491,3341,3201,3071,2931,2791,26521,20220,88720,58094,6641,1971,1821,1951,2001,1481,0318020000211,32628,900059,76059,76046,167
       Short Long Term Debt 
46,167
59,760
59,760
0
206,951
211,326
0
0
0
0
802
0
0
0
0
0
0
93,452
19,354
19,648
19,950
0
0
0
0
0
0
0
0
0
00000000019,95019,64819,35493,4520000008020000211,326206,951059,76059,76046,167
       Accounts payable 
230
2,877
0
0
323
445
1,277
751
661
1,558
1,863
7,708
6,125
5,796
10,699
10,952
2,957
9,615
13,253
8,059
7,365
6,091
7,565
39,023
38
33,729
10,185
7,835
38,473
4,271
4,27138,4737,83510,18533,7293839,0237,5656,0917,3658,05913,2539,6152,95710,95210,6995,7966,1257,7081,8631,5586617511,277445323002,877230
       Other Current Liabilities 
1,704
675
0
0
841
977
2,352
2,933
4,799
3,718
6,735
14,366
18,701
17,443
10,719
7,328
6,184
72,888
50,704
53,806
36,985
42,373
26,864
4,528
12
2,449
22,174
23,224
10,067
31,610
31,61010,06723,22422,1742,449124,52826,86442,37336,98553,80650,70472,8886,1847,32810,71917,44318,70114,3666,7353,7184,7992,9332,352977841006751,704
   > Long-term Liabilities 
0
21,289
0
0
64,454
15,028
71,784
80,315
82,951
82,184
136,172
138,495
139,649
136,546
128,932
131,479
167,975
101,778
46,261
46,439
46,513
117,944
112,714
112,527
112
112,975
112,608
134,597
138,799
161,396
161,396138,799134,597112,608112,975112112,527112,714117,94446,51346,43946,261101,778167,975131,479128,932136,546139,649138,495136,17282,18482,95180,31571,78415,02864,4540021,2890
       Long term Debt Total 
0
0
0
0
0
0
16,149
16,470
16,791
0
89,710
90,270
90,854
91,453
92,059
74,165
114,177
0
0
0
0
71,222
0
0
0
71,879
0
0
0
0
000071,87900071,2220000114,17774,16592,05991,45390,85490,27089,710016,79116,47016,149000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
831
5,178
5,215
5,093
4,912
4,711
4,537
4,359
4,162
3,953
3,740
3,521
3,289
3,046
2,798
2,544
2,274
1,995
6,346
6,187
6,1876,3461,9952,2742,5442,7983,0463,2893,5213,7403,9534,1624,3594,5374,7114,9125,0935,2155,1788310000000000
       Other Liabilities 
46
44
0
0
39
38
71,784
80,315
82,951
82,184
63,586
61,486
62,402
59,145
51,374
53,785
50,458
58,125
43,325
43,725
44,025
44,466
39,323
39,229
39,025
39,872
0
0
0
0
000039,87239,02539,22939,32344,46644,02543,72543,32558,12550,45853,78551,37459,14562,40261,48663,58682,18482,95180,31571,7843839004446
> Total Stockholder Equity
12,002
-7,106
-7,106
0
-15,561
-75,543
51,982
37,935
94,966
-123,025
75,357
41,181
17,043
79,457
62,606
43,603
35,095
-376,072
23,289
106,138
97,404
-422,882
67,248
46,861
29
18,499
6,949
-6,963
-19,368
-20,689
-20,689-19,368-6,9636,94918,4992946,86167,248-422,88297,404106,13823,289-376,07235,09543,60362,60679,45717,04341,18175,357-123,02594,96637,93551,982-75,543-15,5610-7,106-7,10612,002
   Common Stock
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
1
1
1
1
1
111110111111111111111111000000
   Retained Earnings Total Equity00-530,225-512,085-497,294-484,130-463,854-440,383-422,882-404,705-385,272-369,671-376,072-265,378-253,919-232,794-213,0590-171,60000-110,600-98,800-82,300000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-9
43
19
6
225
19
3
0
0
0
0
0
-103
-165
0
-337
-416
-468
-606
-427
-427-606-468-416-3370-165-1030000031922561943-90000000000
   Capital Surplus 
0
0
0
0
0
0
134,301
136,687
205,548
0
209,365
212,704
215,574
292,509
295,174
297,502
300,469
303,113
392,959
491,409
502,108
504,757
507,733
510,879
513,717
516,129
519,449
523,729
0
0
00523,729519,449516,129513,717510,879507,733504,757502,108491,409392,959303,113300,469297,502295,174292,509215,574212,704209,3650205,548136,687134,301000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
0
59,700
0
0
62,923
0
134,301
136,687
205,548
-1
209,365
212,704
215,574
292,509
295,174
297,502
300,469
-1
392,959
491,409
502,108
-1
507,733
510,879
463,903
516,129
519,449
523,729
528,385
538,716
538,716528,385523,729519,449516,129463,903510,879507,733-1502,108491,409392,959-1300,469297,502295,174292,509215,574212,704209,365-1205,548136,687134,301062,9230059,7000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue202,085
Cost of Revenue-66,692
Gross Profit135,393135,393
 
Operating Income (+$)
Gross Profit135,393
Operating Expense-171,500
Operating Income-36,107-36,107
 
Operating Expense (+$)
Research Development6,556
Selling General Administrative164,944
Selling And Marketing Expenses0
Operating Expense171,500171,500
 
Net Interest Income (+$)
Interest Income860
Interest Expense-13,832
Other Finance Cost-0
Net Interest Income-12,972
 
Pretax Income (+$)
Operating Income-36,107
Net Interest Income-12,972
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-61,509-10,705
EBIT - interestExpense = -49,939
-61,509
-47,853
Interest Expense13,832
Earnings Before Interest and Taxes (EBIT)-36,107-47,677
Earnings Before Interest and Taxes (EBITDA)-30,240
 
After tax Income (+$)
Income Before Tax-61,509
Tax Provision-176
Net Income From Continuing Ops-61,685-61,685
Net Income-61,685
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses238,192
Total Other Income/Expenses Net-25,40212,972
 

Technical Analysis of Evolus
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Evolus. The general trend of Evolus is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Evolus's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Evolus Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 12.70 < 12.90 < 13.55.

The bearish price targets are: 11.49 > 11.45 > 11.27.

Tweet this
Evolus Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Evolus Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Evolus Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Evolus Inc. The current macd is -0.58237007.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evolus price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Evolus. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Evolus price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Evolus Inc Daily Moving Average Convergence/Divergence (MACD) ChartEvolus Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Evolus Inc. The current adx is 29.73.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Evolus shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Evolus Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Evolus Inc. The current sar is 12.50.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Evolus Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Evolus Inc. The current rsi is 24.68. The current phase is Oversold in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bull market: Short-term excessive selling, potential for rebound. Consider buying at a perceived discount, watch for reversal signs. +1
  • Trending down: The RSI is trending down. -1
Evolus Inc Daily Relative Strength Index (RSI) ChartEvolus Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Evolus Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evolus price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Evolus Inc Daily Stochastic Oscillator ChartEvolus Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Evolus Inc. The current cci is -92.45592267.

Evolus Inc Daily Commodity Channel Index (CCI) ChartEvolus Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Evolus Inc. The current cmo is -59.70358121.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Evolus Inc Daily Chande Momentum Oscillator (CMO) ChartEvolus Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Evolus Inc. The current willr is -89.42731278.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Evolus Inc Daily Williams %R ChartEvolus Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Evolus Inc.

Evolus Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Evolus Inc. The current atr is 0.44460826.

Evolus Inc Daily Average True Range (ATR) ChartEvolus Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Evolus Inc. The current obv is -342,848.

Evolus Inc Daily On-Balance Volume (OBV) ChartEvolus Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Evolus Inc. The current mfi is 17.65.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Evolus Inc Daily Money Flow Index (MFI) ChartEvolus Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Evolus Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Evolus Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Evolus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.683
Ma 20Greater thanMa 5012.675
Ma 50Greater thanMa 10013.468
Ma 100Greater thanMa 20012.262
OpenGreater thanClose11.680
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Evolus with someone you think should read this too:
  • Are you bullish or bearish on Evolus? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Evolus? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Evolus Inc

I send you an email if I find something interesting about Evolus Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Evolus Inc.

Receive notifications about Evolus Inc in your mailbox!